Our Private Equity Group is considered the go-to practice for complex, bespoke and firm-defining transactions. With clients ranging from the world’s leading institutional asset managers to prominent middle-market private equity and growth equity firms, we offer comprehensive advice to general partners, limited partners, co-investors and other equity stakeholders, as well as portfolio companies, lenders and financial sponsor groups. The depth and continuity of our relationships across the industry gives us a nuanced understanding of each client’s objectives and allows us to provide seamless, efficient counsel across the investment lifecycle.
General Atlantic Invests in LePure Biotech
- Client News
- January 18, 2023
Paul, Weiss advised General Atlantic in its Series C investment in Shanghai LePure Biotech Co., Ltd. (LePure Biotech), a China-based single-use solutions provider for biopharmaceutical companies. General Atlantic co-led the funding round alongside Novo Holdings and Goldman Sachs Asset Management, with participation from existing investors including Highlight Capital, Bayland Capital and HM Capital. Financial terms of the transaction were not disclosed.
LePure will use the funding to accelerate product innovation, promote overseas expansion and enhance the company’s competitiveness and influence in the global industrial chain.
The Paul, Weiss team included corporate partner Judie Ng Shortell and counsel Jack Sun; tax partner Lindsay Parks; antitrust counsel Marta Kelly; and international trade counsel Richard Elliott.